Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Effect of informed consent on patient characteristics in a stroke thrombolysis trial.

Thomalla G, Boutitie F, Fiebach JB, Simonsen CZ, Nighoghossian N, Pedraza S, Lemmens R, Roy P, Muir KW, Heesen C, Ebinger M, Ford I, Cheng B, Cho TH, Puig J, Thijs V, Endres M, Fiehler J, Gerloff C.

Neurology. 2017 Sep 26;89(13):1400-1407. doi: 10.1212/WNL.0000000000004414. Epub 2017 Aug 25.

2.

Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial).

Thomalla G, Boutitie F, Fiebach JB, Simonsen CZ, Nighoghossian N, Pedraza S, Lemmens R, Roy P, Muir KW, Ebinger M, Ford I, Cheng B, Galinovic I, Cho TH, Puig J, Thijs V, Endres M, Fiehler J, Gerloff C; WAKE-UP Investigators.

Stroke. 2017 Mar;48(3):770-773. doi: 10.1161/STROKEAHA.116.015233. Epub 2017 Feb 7.

PMID:
28174327
3.

Which factors influence the resort to surrogate consent in stroke trials, and what are the patient outcomes in this context?

Mendyk AM, Labreuche J, Henon H, Girot M, Cordonnier C, Duhamel A, Leys D, Bordet R.

BMC Med Ethics. 2015 Apr 24;16:26. doi: 10.1186/s12910-015-0018-8.

4.

A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).

Thomalla G, Fiebach JB, Østergaard L, Pedraza S, Thijs V, Nighoghossian N, Roy P, Muir KW, Ebinger M, Cheng B, Galinovic I, Cho TH, Puig J, Boutitie F, Simonsen CZ, Endres M, Fiehler J, Gerloff C; WAKE-UP investigators.

Int J Stroke. 2014 Aug;9(6):829-36. doi: 10.1111/ijs.12011. Epub 2013 Mar 12.

PMID:
23490032
5.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

PMID:
12869717
6.

[EU-funded treatment study: WAKE-UP: a randomized, placebo-controlled MRI-based trial of thrombolysis in wake-up stroke].

Thomalla G, Ebinger M, Fiehler J, Fiebach JB, Endres M, Gerloff C.

Nervenarzt. 2012 Oct;83(10):1241-51. doi: 10.1007/s00115-012-3532-7. German.

PMID:
23015193
7.

Consent to thrombolysis in acute ischaemic stroke: from trial to practice.

Ciccone A.

Lancet Neurol. 2003 Jun;2(6):375-8.

PMID:
12849154
8.

Consent for intravenous thrombolysis in acute stroke: review and future directions.

White-Bateman SR, Schumacher HC, Sacco RL, Appelbaum PS.

Arch Neurol. 2007 Jun;64(6):785-92. Review.

PMID:
17562926
9.

How important is surrogate consent for stroke research?

Flaherty ML, Karlawish J, Khoury JC, Kleindorfer D, Woo D, Broderick JP.

Neurology. 2008 Nov 11;71(20):1566-71. doi: 10.1212/01.wnl.0000316196.63704.f5. Epub 2008 Aug 27.

PMID:
18753472
10.

Ischemic stroke survivors' opinion regarding research utilizing exception from informed consent.

Kleindorfer D, Lindsell CJ, Alwell K, Woo D, Flaherty ML, Eilerman J, Khatri P, Adeoye O, Ferioli S, Kissela BM.

Cerebrovasc Dis. 2011;32(4):321-6. doi: 10.1159/000328815. Epub 2011 Sep 15.

11.

Selection bias in clinical stroke trials depending on ability to consent.

Hotter B, Ulm L, Hoffmann S, Katan M, Montaner J, Bustamante A, Meisel A.

BMC Neurol. 2017 Dec 4;17(1):206. doi: 10.1186/s12883-017-0989-9.

12.

I don't like that, it's tricking people too much...: acute informed consent to participation in a trial of thrombolysis for stroke.

Mangset M, Førde R, Nessa J, Berge E, Wyller TB.

J Med Ethics. 2008 Oct;34(10):751-6. doi: 10.1136/jme.2007.023168.

PMID:
18827109
13.

Brain lesion volume and capacity for consent in stroke trials: potential regulatory barriers to the use of surrogate markers.

Dani KA, McCormick MT, Muir KW.

Stroke. 2008 Aug;39(8):2336-40. doi: 10.1161/STROKEAHA.107.507111. Epub 2008 Jun 5.

PMID:
18535280
14.

Dissociation of severity of stroke and aphasia recovery early after intravenous recombinant tissue plasminogen activator thrombolysis.

Kremer C, Kappelin J, Perren F.

J Clin Neurosci. 2014 Oct;21(10):1828-30. doi: 10.1016/j.jocn.2014.01.010. Epub 2014 May 19.

PMID:
24852905
15.

THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial.

Koga M, Toyoda K, Kimura K, Yamamoto H, Sasaki M, Hamasaki T, Kitazono T, Aoki J, Seki K, Homma K, Sato S, Minematsu K; THAWS investigators.

Int J Stroke. 2014 Dec;9(8):1117-24. doi: 10.1111/ijs.12360. Epub 2014 Aug 4.

16.

Inability to consent does not diminish the desirability of stroke thrombolysis.

Chiong W, Kim AS, Huang IA, Farahany NA, Josephson SA.

Ann Neurol. 2014 Aug;76(2):296-304. doi: 10.1002/ana.24209. Epub 2014 Jul 9.

17.

Continuous magnetic resonance perfusion imaging acquisition during systemic thrombolysis in acute stroke.

Griebe M, Kern R, Eisele P, Sick C, Wolf ME, Sauter-Servaes J, Gregori J, Günther M, Hennerici MG, Szabo K.

Cerebrovasc Dis. 2013;35(6):554-9. doi: 10.1159/000351146. Epub 2013 Jul 6.

PMID:
23838705
18.

Informed Consent for Intravenous Tissue Plasminogen Activator in New York State Designated Stroke Centers.

Weintraub MI, Colello AD, Johnson SA, McClellan F, Cole SP, Benesch C, Rudolph SH, Levine SR.

J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1274-1279. doi: 10.1016/j.jstrokecerebrovasdis.2017.01.021. Epub 2017 Feb 8.

PMID:
28189569
19.

Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice.

Rosenbaum JR, Bravata DM, Concato J, Brass LM, Kim N, Fried TR.

Stroke. 2004 Sep;35(9):e353-5. Epub 2004 Jul 8.

PMID:
15243145
20.

Ethical issues of informed consent in acute stroke. Analysis of the modalities of consent in 56 patients enrolled in urgent therapeutic trials.

Demarquay G, Derex L, Nighoghossian N, Adeleine P, Philippeau F, Honnorat J, Trouillas P.

Cerebrovasc Dis. 2005;19(2):65-8. Epub 2005 Jan 11.

PMID:
15644623

Supplemental Content

Support Center